![Paolo Tarantino: Mark your calendars for PER’s 6th Annual Precision Medicine Symposium](https://oncodaily.com/pub/uploads/2024/05/GODRoV8WkAAC0aX.png)
Paolo Tarantino: Mark your calendars for PER’s 6th Annual Precision Medicine Symposium
Paolo Tarantino made the following post on X:
“Mark your calendars for PER’s 6th Annual Precision Medicine Symposium this October 18-19!
Register for FREE using TARANTINO as a discount code and don’t miss this CME opportunity!
Link.”
Source: Paolo Tarantino/X
Dr. Paolo Tarantino, MD researcher, holds positions at both the European Institute of Oncology in Milan, Italy, and the Dana-Farber Cancer Institute in Boston, MA, Specializing in breast cancer. Currently, Dr. Tarantino is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.
.
His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a robust publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field. Dr. Tarantino’s dedication and innovative approach contribute significantly to the advancement of breast cancer treatment and research.